Published • loading... • Updated
What Aquestive Therapeutics (AQST) Said on Its Q3 Earnings Call
Summary by MarketBeat
3 Articles
3 Articles
MarketBeatReposted by 
thecerbatgem.com
thecerbatgem.comWhat Aquestive Therapeutics (AQST) Said on Its Q3 Earnings Call
Aquestive Therapeutics (NASDAQ:AQST) said it resubmitted its application for Anaphylm, an epinephrine sublingual film intended for severe allergic reactions, before the end of the third quarter and is preparing for a potential U.S. launch next year if the product receives Food and Drug Administratio
·Sioux Falls, United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
